What is the main business of Relyonart Biotech Investment Fund Inc.?

The main business activity of Relyonart Biotech Investment Fund Inc. focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on May 13, 2014.

Where is the headquarters located?

The headquarters is located at: ul. Wołoska 9, 02-583 Warszawa.

Who is on the management board?

The management board consists of: Adam Maciej Cudny (President of the Management Board) and Paweł Straszyński (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

The company reported a revenue of $191 in 2025.

Is the company profitable?

Yes, in 2025 the company achieved a net profit of $42.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to $148 in 2025, representing 100% of all operating expenses.

Relyonart Biotech Investment Fund Inc.sp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2014-05-13

Share capital

5,000.00 PLN

Registered address

ul. Wołoska 9, 02-583 Warszawa, Poland

Financials

Revenue history

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 89 days for 2021).

202503/08/2026
202420/05/2025
202317/07/2024
202227/07/2023
202112/10/2022
202014/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 190.86MedianUSD 55.24kAverageUSD 2.71m

Net profit

This companyUSD 42.34MedianUSD -1.27kAverageUSD -91.85k

Operating costs

This companyUSD 148.27MedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 257.00MedianUSD 133.19kAverageUSD 3.03m

Industry

Authorized Representatives

Adam Maciej Cudny – President of the Management Board

Paweł Straszyński – Management Board Member

Manner of representation

The company is represented by: A. the President of the Management Board independently; B. two members of the management board acting jointly or one member of the management board together with a commercial proxy, acting jointly.

Ownership

Owner	Shares	Share value	Stake
Relyonart Fund sp. z o.o. + limited partnership	100	$1,350.62	100%

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2014-04-16 to 2025-12-31.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
RDLSsp. z o.o.	$1,680,515.32	rdls.pl
ModicaP.S.A.	$103,400.72	modica.bio
WPD Pharmaceuticalssp. z o.o.	$90,822.78	wpdpharmaceuticals.com
WPD PharmaceuticalsS.A.	$87,561.70	wpdpharmaceuticals.pl
Stenocoatsp. z o.o.	$36,665.21	stenocoat.com
Platforma Badań Genetycznychsp. z o.o.	$28,558.39	zdrowegeny.pl
Bioselsp. z o.o.	$19,100.32	selol.pl
Omnisepticasp. z o.o.	$3,475.29	omniseptica.com
Wavex Energysp. z o.o.	$142.33	wavexenergy.com
Getgetsp. z o.o.	–	getget.pl

Change history

Date	Event
2022-07-12	Name change (Relyonart Biotech Investment Fund → Relyonart Biotech Investment Fund Inc.)
2015-03-13	Address change (Pańska 96/83, 00-837, Warszawa → Ul. Wołoska 9, 02-583, Warszawa)
2015-03-13	Name change (Helus → Relyonart Biotech Investment Fund)
2015-03-13	PKD change (Removed: 63 codes; Added: 10 codes)
2014-05-13	Entered in the register

FAQ

Last updated: 2026-10-07